Abstract

Background This study aimed to assess the safety and feasibility of endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) using a lumen-apposing metal stent (LAMS) as a primary drainage strategy in patients with distal malignant biliary obstruction (MBO). Methods A prospective, single-center, pilot study was conducted in patients with pathology-confirmed MBO without gastric outlet obstruction. The primary outcome was technical success. Secondary outcomes included clinical success, adverse events (AEs), and reinterventions. The study was registered in the Netherlands Trial Registry (registry number NL9757). Results 22 patients were enrolled (median age 69.5 years [interquartile range 64.75.3]). Technical success was achieved in 20/22 patients (91%). AEs occurred in one patient, namely perforation following inadequate stent deployment (5 %), which was treated in the same procedure. Clinical success was achieved in 19/22 patients (86%). Stent dysfunction was observed in 11/20 patients (55%) after technically successful EUS-CDS: two patients were treated conservatively and nine patients underwent reintervention (s). One patient died within . 30 days due to fulminant disease progression. Conclusions The results confirmed the safety and feasibility of EUS-CDS using LAMS as a primary drainage strategy. The high incidence of stent dysfunction should be improved before EUS-CDS with LAMS can be seen as a valid alternative to endoscopic retrograde cholangiopancreatography.

Original languageEnglish
Pages (from-to)47-52
Number of pages6
JournalEndoscopy
Volume56
Issue number1
Early online date2023
DOIs
Publication statusPublished - 13 Feb 2023

Keywords

  • Biliary drainage
  • EUS-guided choledochoduodenostomy
  • Malignant distal biliary obstruction

Cite this